[ET Net News Agency, 8 April 2024] Citi lowered the target price for Junshi Bio (01877)
to HKD17 from HKD55 and maintained the "buy/high risk" rating.
The research house said it cuts FY24/25E revenue estimates by 18%/16% to reflect the
latest sales trend. (RC)